Status:
COMPLETED
A Comparative Study of Supine Position and the Head Elevated Position on the Level of Sensory Block After Spinal Anesthesia in Morbidly Obese Parturient Undergoing Elective Cesarean Delivery
Lead Sponsor:
Hamad Medical Corporation
Conditions:
High BMI
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The sniffing position defined as neck flexion with upper cervical extension, is traditionally recommended for general anesthesia induction, as it improves laryngoscopic views. However, the head elevat...
Eligibility Criteria
Inclusion
- Age 18yrs of age or more
- BMI 40 or more and more than or equal 37 weeks of gestation
- elective CD
- consented for neuraxial anesthesia
- singleton fetus
- ASA class 3 (no co-morbidities except morbid obesity, gestational diabetes, and gestational hypothyroidism)
Exclusion
- Age \<18 years
- BMI less than 39.9 and \<37 weeks of gestation
- parturient preference for general anesthesia or contraindication to neuraxial anesthesia
- Women with comorbidities other than obesity, gestational diabetes or gestational hypothyroidism.
- women in active labor (\>3 cm dilated with regular uterine contractions)
- emergency CD
- Possible uterine over-distension or under-distension (e.g. polyhydramnios, estimated fetal weight \>4 kg by ultrasound scan, or oligohydramnios or concern for fetal IUGR)
- maternal height \<150 cm or \>180 cm.
- Patients for which more than 2 minutes is taken in positioning after anesthesia induction (Time 0).
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06889337
Start Date
May 1 2023
End Date
December 10 2024
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Qatar